Devsaagar Thanki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Devsaagar Thanki has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Woodacre
University of Northampton, United Kingdom
1 shared publication - Andrew F. Maule
Department of Plant and Agroecosystem Sciences, University of Wisconsin-Madison, Madison, USA
1 shared publication - Andrew T. Ulijasz
Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
1 shared publication - David G. Glanville
Division of Pulmonary, Allergy and Critical Care, Department of Medicine, University of Alabama at Birmingham
1 shared publication - Deirdre A. Lane
Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK
1 shared publication - Dipak Kotecha
Department of Cardiovascular Sciences, University of Birmingham, Birmingham, UK
1 shared publication
Latest Publications
- Open Access
- 11 May 2018
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 14 (5) , e1007052
RitR is an archetype for a novel family of redox sensors in the streptococci that has evolved from two-component response regulators and is required for pneumococcal colonization
To survive diverse host environments, the human pathogen Streptococcus pneumoniae must prevent its self-produced, extremely high levels of peroxide from reacting with intracellular iron. However, the regulatory mechanism(s) by which the pneumococcus accomplishes this balance remains largely enigmatic, as this pathogen and other related streptococci lack all known redox-sensing transcription factors. Here we describe a two-component-derived response regulator, RitR, as the archetype for a novel family of redox sensors in a subset of streptococcal species. We show that RitR works to both repress iron transport and enable nasopharyngeal colonization through a mechanism that exploits a single cysteine (Cys128) redox switch located within its linker domain. Biochemical experiments and phylogenetics reveal that RitR has diverged from the canonical two-component virulence regulator CovR to instead dimerize and bind DNA only upon Cys128 oxidation in air-rich environments. Atomic structures show that Cys128 oxidation initiates a “helical unravelling” of the RitR linker region, suggesting a mechanism by which the DNA-binding domain is then released to interact with its cognate regulatory DNA. Expanded computational studies indicate this mechanism could be shared by many microbial species outside the streptococcus genus. Most life requires elemental iron for survival. Bacterial pathogens are no exception, where within the host environment iron availability can “make or break” a successful infection. However, with healthy intracellular iron levels come great risks, as microbes must then strive to keep the needed iron from reacting with hydrogen peroxide and other oxidants, which can ultimately result in cellular damage and death. The bacterial pathogen Streptococcus pneumoniae is unusual in that it possesses both high intracellular iron and peroxide levels, a perceived recipe for suicide. To date, how S. pneumoniae and related pathogens contend with regulating this destructive cocktail has remained a mystery, as they lack all typical redox-sensing factors known to alert the cell of such danger. Here we describe the transcription factor RitR as an archetype redox-sensing regulatory protein in S. pneumoniae and related species. RitR works through alerting the cell of high peroxide levels in the airways through oxidation of its single cysteine residue, initiating DNA-binding to further repress the damaging iron from entering the cell. Importantly, this mechanism enables colonization of the nasopharynx, an event which is required for invasiveness. Analyses of bacterial genomes suggest that this mechanism could be conserved far outside the streptococcal species.
- 11 May 2018
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 14 (5) , e1007052
Open AccessRitR is an archetype for a novel family of redox sensors in the streptococci that has evolved from two-component response regulators and is required for pneumococcal colonization
To survive diverse host environments, the human pathogen Streptococcus pneumoniae must prevent its self-produced, extremely high levels of peroxide from reacting with intracellular iron. However, the regulatory mechanism(s) by which the pneumococcus accomplishes this balance remains largely enigmatic, as this pathogen and other related streptococci lack all known redox-sensing transcription factors. Here we describe a two-component-derived response regulator, RitR, as the archetype for a novel family of redox sensors in a subset of streptococcal species. We show that RitR works to both repress iron transport and enable nasopharyngeal colonization through a mechanism that exploits a single cysteine (Cys128) redox switch located within its linker domain. Biochemical experiments and phylogenetics reveal that RitR has diverged from the canonical two-component virulence regulator CovR to instead dimerize and bind DNA only upon Cys128 oxidation in air-rich environments. Atomic structures show that Cys128 oxidation initiates a “helical unravelling” of the RitR linker region, suggesting a mechanism by which the DNA-binding domain is then released to interact with its cognate regulatory DNA. Expanded computational studies indicate this mechanism could be shared by many microbial species outside the streptococcus genus. Most life requires elemental iron for survival. Bacterial pathogens are no exception, where within the host environment iron availability can “make or break” a successful infection. However, with healthy intracellular iron levels come great risks, as microbes must then strive to keep the needed iron from reacting with hydrogen peroxide and other oxidants, which can ultimately result in cellular damage and death. The bacterial pathogen Streptococcus pneumoniae is unusual in that it possesses both high intracellular iron and peroxide levels, a perceived recipe for suicide. To date, how S. pneumoniae and related pathogens contend with regulating this destructive cocktail has remained a mystery, as they lack all typical redox-sensing factors known to alert the cell of such danger. Here we describe the transcription factor RitR as an archetype redox-sensing regulatory protein in S. pneumoniae and related species. RitR works through alerting the cell of high peroxide levels in the airways through oxidation of its single cysteine residue, initiating DNA-binding to further repress the damaging iron from entering the cell. Importantly, this mechanism enables colonization of the nasopharynx, an event which is required for invasiveness. Analyses of bacterial genomes suggest that this mechanism could be conserved far outside the streptococcal species.
- Open Access
- 22 July 2017
- Published by Springer Nature in Heart Failure Reviews
- Vol. 22 (6) , 731-741
Effects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis
This systematic review and meta-analysis aimed to evaluate the effects of cognitive behavioural therapy (CBT) on depression, quality of life, hospitalisations and mortality in heart failure patients. The search strategy was developed for Ovid MEDLINE and modified accordingly to search the following bibliographic databases: PubMed, EMBASE, PsycINFO, CENTRAL and CINAHL. Databases were searched from inception to 6 March 2016 for randomised controlled trials (RCTs) or observational studies that used CBT in heart failure patients with depression or depressive symptoms. Six studies were identified: 5 RCTs and 1 observational study, comprising 320 participants with predominantly NYHA classes II-III, who were mostly male, with mean age ranging from 55 to 66 years. Compared to usual care, CBT was associated with a greater improvement in depression scores both initially after CBT sessions (standardised mean difference −0.34, 95% CI −0.60 to −0.08, p = 0.01) and at 3 months follow-up (standardised mean difference −0.32, 95% CI −0.59 to −0.04, p = 0.03). Greater improvement in quality of life scores was evident for the CBT group initially after CBT sessions, but with no difference at 3 months. Hospital admissions and mortality were similar, regardless of treatment group. CBT may be more effective than usual care at improving depression scores and quality of life for heart failure patients initially following CBT and for depression at 3 months. Larger and more robust RCTs are needed to evaluate the long-term clinical effects of CBT in heart failure patients.
- 22 July 2017
- Published by Springer Nature in Heart Failure Reviews
- Vol. 22 (6) , 731-741
Open AccessEffects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis
This systematic review and meta-analysis aimed to evaluate the effects of cognitive behavioural therapy (CBT) on depression, quality of life, hospitalisations and mortality in heart failure patients. The search strategy was developed for Ovid MEDLINE and modified accordingly to search the following bibliographic databases: PubMed, EMBASE, PsycINFO, CENTRAL and CINAHL. Databases were searched from inception to 6 March 2016 for randomised controlled trials (RCTs) or observational studies that used CBT in heart failure patients with depression or depressive symptoms. Six studies were identified: 5 RCTs and 1 observational study, comprising 320 participants with predominantly NYHA classes II-III, who were mostly male, with mean age ranging from 55 to 66 years. Compared to usual care, CBT was associated with a greater improvement in depression scores both initially after CBT sessions (standardised mean difference −0.34, 95% CI −0.60 to −0.08, p = 0.01) and at 3 months follow-up (standardised mean difference −0.32, 95% CI −0.59 to −0.04, p = 0.03). Greater improvement in quality of life scores was evident for the CBT group initially after CBT sessions, but with no difference at 3 months. Hospital admissions and mortality were similar, regardless of treatment group. CBT may be more effective than usual care at improving depression scores and quality of life for heart failure patients initially following CBT and for depression at 3 months. Larger and more robust RCTs are needed to evaluate the long-term clinical effects of CBT in heart failure patients.